nufacturing, marketing and distribution of
pharmaceutical, medicinal and diagnostic products. Through its wholly-owned
subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company
(''TDR''), Harbin First Bio- Engineering Company Limited ("First"),
Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin
Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and
distributes over-the-counter pharmaceutical products, which make up its major
revenue source. For more information, visit
http://www.skyonemedical.com .
Safe Harbor Statement
Certain of the statements made in the press release constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements can be identified by the use
of forward- looking terminology such as "believe," "expect," "may," "will,"
"should," "project," "plan," "seek," "intend," or "anticipate" or the negative
thereof or comparable terminology. Such statements typically involve risks and
uncertainties and may include financial projections or information regarding
our future plans, objectives or performance. Actual results could differ
materially from the expectations reflected in such forward-looking statements
as a result of a variety of factors, including the risks associated with the
effect of changing economic conditions in The People's Republic of China,
variations in cash flow, reliance on collaborative retail partners and on new
product development, variations in new product development, risks associated
with rapid technological change, and the potential of introduced or undetected
flaws and defects in products, and other risk factors detailed in reports
filed with the Securities and Exchange Commission from time to time.
For more information, please contact:
Company Contact:
China Sky One Medical,
'/>"/>
SOURCE China Sky One Medical, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Health Robotics Announces Partnership in the Peoples Republic of China With The Devon International Group2.
China Sky One Medical, Inc. Receives Scientific Achievement Award3.
China Medicine to Distribute Dental and Surgical Instruments4.
HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China5.
VIASPACE Plants Biofuel & Animal Feed Grass and Signs Land Lease in China6.
China Sky One Medical, Inc. Interviewed in The China Perspective7.
China Medicine Corporation Awarded GSP Certification8.
NSD Bio Group, LLC chosen by U.S.-China Economic & Security Review Commission for Report on Chinas High Tech Sectors9.
China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits10.
China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs11.
China Biologic Products Reports Strong Third Quarter 2008 Results